March 2020 - Page 39 of 342

NASDAQ Companies - March 30, 2020

Newtek Business Services Corp. Outlines Sections of the $2.0 Trillion Coronavirus Stimulus Package as it Relates to its SBA 7(a) Business

BOCA RATON, Fla., March 30, 2020 (GLOBE NEWSWIRE) — Newtek Business Services Corp., (NASDAQ: NEWT), an internally managed business development […]

NASDAQ Companies - March 30, 2020

Neos Therapeutics Statement: COVID-19 Update

DALLAS and FORT WORTH, Texas, March 30, 2020 (GLOBE NEWSWIRE) — Jerry McLaughlin, President and CEO, made the following statement:We […]

NASDAQ Companies - March 30, 2020

Assembly Biosciences Appoints Jason Okazaki as Chief Legal and Business Officer

SOUTH SAN FRANCISCO, Calif., March 30, 2020 (GLOBE NEWSWIRE) — Assembly Biosciences, Inc. (NASDAQ: ASMB), a clinical-stage biotechnology company developing […]

NASDAQ Companies - March 30, 2020

Ovid Therapeutics Announces Initial Data with Soticlestat in CDKL5 Deficiency Disorder and Dup15q Syndrome

Soticlestat continues to appear to be safe and well-tolerated; the majority of the 11 patients showed a reduction in seizuresAll […]

NASDAQ Companies - March 30, 2020

Capital City Bank Group, Inc. Announces Change to Virtual Format for Annual Meeting of Shareowners to Be Held April 23, 2020

TALLAHASSEE, Fla., March 30, 2020 (GLOBE NEWSWIRE) — Capital City Bank Group (NASDAQ: CCBG) announced today that, due to the […]

NASDAQ Companies - March 30, 2020

Daré Bioscience Reports 2019 Financial Results and Provides a Company Update

SAN DIEGO, March 30, 2020 (GLOBE NEWSWIRE) — Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today reported […]

NASDAQ Companies - March 30, 2020

RAPT Therapeutics Reports Fourth Quarter 2019 Financial Results and Provides Business Update

SOUTH SAN FRANCISCO, Calif., March 30, 2020 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused […]

NASDAQ Companies - March 30, 2020

I-Mab Enters into Strategic Regional Partnership with Kalbe Genexine Biologics for Commercialization Rights of CD73 Antibody, TJD5, for Immuno-Oncology

– Kalbe Genexine Biologics (“KG Bio”) will receive right of first negotiation for an exclusive license to potentially commercialize I-Mab’s […]

NASDAQ Companies - March 30, 2020

Chuy’s Holdings, Inc. Provides COVID-19 Update

AUSTIN, Texas, March 30, 2020 (GLOBE NEWSWIRE) — Chuy’s Holdings, Inc. (NASDAQ:CHUY) today provided a business update in light of […]

NASDAQ Companies - March 30, 2020

Rhythm Pharmaceuticals Provides Updates on Leadership Transition and Business Operations

Hunter Smith, Chief Financial Officer, appointed Interim Chief Executive Officer following completion of NDA submission to FDA Precautionary measures in place […]